InsidersTradesSigma
Follow the Foundation Medicine, Inc. share price and the full management transaction log of the company, a publicly traded company based in United States. Shares are quoted on the US market, under the oversight of SEC (Form 4). Market capitalisation: €2.2bn. The latest transaction was filed on 6 January 2016 (Cession). Among the most active insiders: Kafka Steven J.. Every trade is accessible without an account.
Analysts rate Foundation Medicine, Inc. Strong Buy (bullish), based on 12 analysts. Average price target: US$59.30.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
Foundation Medicine, Inc. is a company focused on developing genomic tests for cancer. It provides solutions that assist physicians in personalizing treatments for their patients.